Last reviewed · How we verify

NCT03525314

Development of Achilles Tendon Elongation and Its Effect on Physical Function the First Year After Rupture

Completed Last updated 16 March 2022
What this trial tests

trial in Achilles Tendon Rupture in 67 participants. Completed in 10 December 2020.

Timeline
6 June 2018
Primary endpoint
10 December 2020
10 December 2020

Quick facts

Lead sponsorHvidovre University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment67
Start date6 June 2018
Primary completion10 December 2020
Estimated completion10 December 2020
Sites1 location across Denmark

Conditions studied

Sponsor

Hvidovre University Hospital

Who can join

Adults 18 to 65, any sex, with Achilles Tendon Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to examine how elongation of the Achilles tendon develops during the first year after rupture among patients with an Achilles tendon rupture, and how it affects physical function. The aim is to define a cutoff of acceptable elongation dividing the patients who obtain normal physical function (Limb Symmetry Index \> 90%) from those who do not. Patients treated both operatively and non-operatively will be included.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Individualized treatment for acute Achilles tendon rupture based on the Copenhagen Achilles Rupture Treatment Algorithm (CARTA): a study protocol for a multicenter randomized controlled trial.
    Hansen MS, Vestermark MT, Hölmich P, Kristensen MT, et al · · 2020 · cited 7× · PMID 32398120 · DOI 10.1186/s13063-020-04332-z

Verify or expand the search:

Other recruiting trials for Achilles Tendon Rupture

Currently open trials in the same condition.

Other Hvidovre University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525314.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing